|
Build Your Online Product Catalogs?
The current methods for ***ecting TB drug resistance are inefficient and imprecise, leading to covering drugs that either cause or exacerbate drug resistance. Chromosomal genetic variation is the primary mechanism through which TB develops resistance to treatment.
A quick diagnosis of multidrug-resistant tuberculosis is now possible due to advances in gene chip ***ection technology, which can evaluate a patient¡¯s resistance to rifampicin and isoniazid, two of the most important first-line anti-tuberculosis medications.
Features of MTB ***ection
Get through all of the tests in 6 hours
Mycobacterium TB rifampicin and isoniazid resistance ***ection in a single sample
A total of 1186 cases were confirmed through clinical trials, and all of them matched up with the sequencing data
Targets Rifampicin resistance gene Isoniazid resistance gene Drug resistance gene rpoB gene katG gene inhA gene loci 511/513/516/526/531/ 315 -15 533
Specification of MTB Drug Resistant ***ection Order information Cat. No. Description Specification 301035 CapitalBioM.Tuberculosis Drug Resistance ***ection Array Kit 12 tests/kit
If you want to know more about mtb dna ***ected process, please visit our website.
With 20+ years¡¯ experience, national scientific research platforms and bioinformatics expertise, Capitalbio Technology always dedicated to assisting researchers advance the life sciences. We have professional scientists to provide services for the whole process, from free consulting and experiment design to data interpretation.
Now the price of in vitro diagnostics kits if reasonable, if you have needs, please contact us. |
Company: |
CapitalBio Technology Co., Ltd.
|
Contact: |
Ms. capitalbio technology |
Address: |
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing |
Postcode: |
|
Tel: |
86-10-69002900 |
Fax: |
|
E-mail: |
|
|
|
|